Skip to main content
Erschienen in: Pituitary 1/2012

01.12.2012

Polyuria and polydipsia in a young child: diagnostic considerations and identification of novel mutation causing familial neurohypophyseal diabetes insipidus

verfasst von: Matthew D. Stephen, Raymond G. Fenwick, Patrick G. Brosnan

Erschienen in: Pituitary | Sonderheft 1/2012

Einloggen, um Zugang zu erhalten

Abstract

A 3-year 5-month-old boy was seen for second opinion regarding polydipsia and polyuria. Previously, a diagnosis of primary polydipsia was made after normal urine concentration after overnight water deprivation testing. The boy’s father, paternal grandfather, and paternal aunt had diabetes insipidus treated with desmopressin acetate. Based on this young boy’s symptoms, ability to concentrate urine after informal overnight water deprivation, and family history of diabetes insipidus, we performed AVP gene mutation testing. Analysis of the AVP gene revealed a novel mutation G54E that changes a normal glycine to glutamic acid, caused by a guanine to adenine change at nucleotide g.1537 (exon 2) of the AVP gene. Commonly, patients with familial neurohypophyseal diabetes insipidus (FNHDI) present within the first 6 years of life with progressively worsening polyuria and compensatory polydipsia. Since these patients have progressive loss of arginine vasopressin (AVP), they may initially respond normally to water deprivation testing and have normal pituitary findings on brain MRI. Genetic testing may be helpful in these patients, as well as preemptively diagnosing those with a mutation, thereby avoiding unnecessary surveillance of those unaffected.
Literatur
1.
Zurück zum Zitat Fluck CE, Deladoey J, Nayak S, Zeller O, Kopp P, Mullis PE (2001) Autosomal dominant neurohypophyseal diabetes insipidus in a Swiss family, caused by a novel mutation (C59Delta/A60W) in the neurophysin moiety of prepro-vasopressin-neurophysin II (AVP-NP II). Eur J Endocrinol 145(4):439–444PubMedCrossRef Fluck CE, Deladoey J, Nayak S, Zeller O, Kopp P, Mullis PE (2001) Autosomal dominant neurohypophyseal diabetes insipidus in a Swiss family, caused by a novel mutation (C59Delta/A60W) in the neurophysin moiety of prepro-vasopressin-neurophysin II (AVP-NP II). Eur J Endocrinol 145(4):439–444PubMedCrossRef
2.
Zurück zum Zitat Polymeropoulos MH, Swift RG, Swift M (1994) Linkage of the gene for Wolfram syndrome to markers on the short arm of chromosome 4. Nat Genet 8(1):95–97PubMedCrossRef Polymeropoulos MH, Swift RG, Swift M (1994) Linkage of the gene for Wolfram syndrome to markers on the short arm of chromosome 4. Nat Genet 8(1):95–97PubMedCrossRef
3.
Zurück zum Zitat Inoue H, Tanizawa Y, Wasson J, Behn P, Kalidas K, Bernal-Mizrachi E et al (1998) A gene encoding a transmembrane protein is mutated in patients with diabetes mellitus and optic atrophy (Wolfram syndrome). Nat Genet 20(2):143–148PubMedCrossRef Inoue H, Tanizawa Y, Wasson J, Behn P, Kalidas K, Bernal-Mizrachi E et al (1998) A gene encoding a transmembrane protein is mutated in patients with diabetes mellitus and optic atrophy (Wolfram syndrome). Nat Genet 20(2):143–148PubMedCrossRef
4.
Zurück zum Zitat Rao VV, Loffler C, Battey J, Hansmann I (1992) The human gene for oxytocin-neurophysin I (OXT) is physically mapped to chromosome 20p13 by in situ hybridization. Cytogenet Cell Genet 61(4):271–273PubMedCrossRef Rao VV, Loffler C, Battey J, Hansmann I (1992) The human gene for oxytocin-neurophysin I (OXT) is physically mapped to chromosome 20p13 by in situ hybridization. Cytogenet Cell Genet 61(4):271–273PubMedCrossRef
5.
Zurück zum Zitat Repaske DR, Phillips JA 3rd, Kirby LT, Tze WJ, D’Ercole AJ, Battey J (1990) Molecular analysis of autosomal dominant neurohypophyseal diabetes insipidus. J Clin Endocrinol Metab 70(3):752–757PubMedCrossRef Repaske DR, Phillips JA 3rd, Kirby LT, Tze WJ, D’Ercole AJ, Battey J (1990) Molecular analysis of autosomal dominant neurohypophyseal diabetes insipidus. J Clin Endocrinol Metab 70(3):752–757PubMedCrossRef
6.
Zurück zum Zitat Sausville E, Carney D, Battey J (1985) The human vasopressin gene is linked to the oxytocin gene and is selectively expressed in a cultured lung cancer cell line. J Biol Chem 260(18):10236–10241PubMed Sausville E, Carney D, Battey J (1985) The human vasopressin gene is linked to the oxytocin gene and is selectively expressed in a cultured lung cancer cell line. J Biol Chem 260(18):10236–10241PubMed
7.
Zurück zum Zitat Crumley J, Bichet D, Morgan K, Arthus MF, Binette D, Lema J, Lonergan M, Michaud A, Turner M, Tzenova J, Yan R. Nephrogenic and neurogenic diabetes insipidus Crumley J, Bichet D, Morgan K, Arthus MF, Binette D, Lema J, Lonergan M, Michaud A, Turner M, Tzenova J, Yan R. Nephrogenic and neurogenic diabetes insipidus
8.
Zurück zum Zitat Willcutts MD, Felner E, White PC (1999) Autosomal recessive familial neurohypophyseal diabetes insipidus with continued secretion of mutant weakly active vasopressin. Human Mol Genet 8(7):1303–1307CrossRef Willcutts MD, Felner E, White PC (1999) Autosomal recessive familial neurohypophyseal diabetes insipidus with continued secretion of mutant weakly active vasopressin. Human Mol Genet 8(7):1303–1307CrossRef
9.
Zurück zum Zitat Land H, Grez M, Ruppert S, Schmale H, Rehbein M, Richter D et al (1983) Deduced amino acid sequence from the bovine oxytocin-neurophysin I precursor cDNA. Nature 302(5906):342–344PubMedCrossRef Land H, Grez M, Ruppert S, Schmale H, Rehbein M, Richter D et al (1983) Deduced amino acid sequence from the bovine oxytocin-neurophysin I precursor cDNA. Nature 302(5906):342–344PubMedCrossRef
10.
Zurück zum Zitat Land H, Schutz G, Schmale H, Richter D (1982) Nucleotide sequence of cloned cDNA encoding bovine arginine vasopressin-neurophysin II precursor. Nature 295(5847):299–303PubMedCrossRef Land H, Schutz G, Schmale H, Richter D (1982) Nucleotide sequence of cloned cDNA encoding bovine arginine vasopressin-neurophysin II precursor. Nature 295(5847):299–303PubMedCrossRef
11.
Zurück zum Zitat Brownstein MJ, Russell JT, Gainer H (1980) Synthesis, transport, and release of posterior pituitary hormones. Science 207(4429):373–378PubMedCrossRef Brownstein MJ, Russell JT, Gainer H (1980) Synthesis, transport, and release of posterior pituitary hormones. Science 207(4429):373–378PubMedCrossRef
12.
Zurück zum Zitat Fassina G, Chaiken IM (1988) Structural requirements of peptide hormone binding for peptide-potentiated self-association of bovine neurophysin II. J Biol Chem 263(27):13539–13543PubMed Fassina G, Chaiken IM (1988) Structural requirements of peptide hormone binding for peptide-potentiated self-association of bovine neurophysin II. J Biol Chem 263(27):13539–13543PubMed
13.
Zurück zum Zitat Rholam M, Nicolas P, Cohen P (1982) Binding of neurohypophyseal peptides to neurophysin dimer promotes formation of compact and spherical complexes. Biochemistry 21(20):4968–4973PubMedCrossRef Rholam M, Nicolas P, Cohen P (1982) Binding of neurohypophyseal peptides to neurophysin dimer promotes formation of compact and spherical complexes. Biochemistry 21(20):4968–4973PubMedCrossRef
14.
Zurück zum Zitat Russell TA, Ito M, Yu RN, Martinson FA, Weiss J, Jameson JL (2003) A murine model of autosomal dominant neurohypophyseal diabetes insipidus reveals progressive loss of vasopressin-producing neurons. J Clin Invest 112(11):1697–1706PubMed Russell TA, Ito M, Yu RN, Martinson FA, Weiss J, Jameson JL (2003) A murine model of autosomal dominant neurohypophyseal diabetes insipidus reveals progressive loss of vasopressin-producing neurons. J Clin Invest 112(11):1697–1706PubMed
15.
Zurück zum Zitat Ito M, Yu RN, Jameson JL (1999) Mutant vasopressin precursors that cause autosomal dominant neurohypophyseal diabetes insipidus retain dimerization and impair the secretion of wild-type proteins. J Biol Chem 274(13):9029–9037PubMedCrossRef Ito M, Yu RN, Jameson JL (1999) Mutant vasopressin precursors that cause autosomal dominant neurohypophyseal diabetes insipidus retain dimerization and impair the secretion of wild-type proteins. J Biol Chem 274(13):9029–9037PubMedCrossRef
16.
Zurück zum Zitat Ito M, Jameson JL (1997) Molecular basis of autosomal dominant neurohypophyseal diabetes insipidus. Cellular toxicity caused by the accumulation of mutant vasopressin precursors within the endoplasmic reticulum. J Clin Invest 99(8):1897–1905PubMedCrossRef Ito M, Jameson JL (1997) Molecular basis of autosomal dominant neurohypophyseal diabetes insipidus. Cellular toxicity caused by the accumulation of mutant vasopressin precursors within the endoplasmic reticulum. J Clin Invest 99(8):1897–1905PubMedCrossRef
17.
Zurück zum Zitat Christensen JH, Siggaard C, Corydon TJ, Robertson GL, Gregersen N, Bolund L et al (2004) Differential cellular handling of defective arginine vasopressin (AVP) prohormones in cells expressing mutations of the AVP gene associated with autosomal dominant and recessive familial neurohypophyseal diabetes insipidus. J Clin Endocrinol Metab 89(9):4521–4531PubMedCrossRef Christensen JH, Siggaard C, Corydon TJ, Robertson GL, Gregersen N, Bolund L et al (2004) Differential cellular handling of defective arginine vasopressin (AVP) prohormones in cells expressing mutations of the AVP gene associated with autosomal dominant and recessive familial neurohypophyseal diabetes insipidus. J Clin Endocrinol Metab 89(9):4521–4531PubMedCrossRef
18.
Zurück zum Zitat Christensen JH, Siggaard C, Corydon TJ, Robertson GL, Gregersen N, Bolund L et al (2004) Impaired trafficking of mutated AVP prohormone in cells expressing rare disease genes causing autosomal dominant familial neurohypophyseal diabetes insipidus. Clin Endocrinol (Oxf) 60(1):125–136CrossRef Christensen JH, Siggaard C, Corydon TJ, Robertson GL, Gregersen N, Bolund L et al (2004) Impaired trafficking of mutated AVP prohormone in cells expressing rare disease genes causing autosomal dominant familial neurohypophyseal diabetes insipidus. Clin Endocrinol (Oxf) 60(1):125–136CrossRef
19.
Zurück zum Zitat Siggaard C, Rittig S, Corydon TJ, Andreasen PH, Jensen TG, Andresen BS et al (1999) Clinical and molecular evidence of abnormal processing and trafficking of the vasopressin preprohormone in a large kindred with familial neurohypophyseal diabetes insipidus due to a signal peptide mutation. J Clin Endocrinol Metab 84(8):2933–2941PubMedCrossRef Siggaard C, Rittig S, Corydon TJ, Andreasen PH, Jensen TG, Andresen BS et al (1999) Clinical and molecular evidence of abnormal processing and trafficking of the vasopressin preprohormone in a large kindred with familial neurohypophyseal diabetes insipidus due to a signal peptide mutation. J Clin Endocrinol Metab 84(8):2933–2941PubMedCrossRef
20.
Zurück zum Zitat Elias PC, Elias LL, Torres N, Moreira AC, Antunes-Rodrigues J, Castro M (2003) Progressive decline of vasopressin secretion in familial autosomal dominant neurohypophyseal diabetes insipidus presenting a novel mutation in the vasopressin-neurophysin II gene. Clin Endocrinol (Oxf) 59(4):511–518CrossRef Elias PC, Elias LL, Torres N, Moreira AC, Antunes-Rodrigues J, Castro M (2003) Progressive decline of vasopressin secretion in familial autosomal dominant neurohypophyseal diabetes insipidus presenting a novel mutation in the vasopressin-neurophysin II gene. Clin Endocrinol (Oxf) 59(4):511–518CrossRef
21.
Zurück zum Zitat Sunyaev S. Polyphen: prediction of functional effects of nsSNPs Sunyaev S. Polyphen: prediction of functional effects of nsSNPs
22.
Zurück zum Zitat Heppner C, Kotzka J, Bullmann C, Krone W, Muller-Wieland D (1998) Identification of mutations of the arginine vasopressin-neurophysin II gene in two kindreds with familial central diabetes insipidus. J Clin Endocrinol Metab 83(2):693–696PubMedCrossRef Heppner C, Kotzka J, Bullmann C, Krone W, Muller-Wieland D (1998) Identification of mutations of the arginine vasopressin-neurophysin II gene in two kindreds with familial central diabetes insipidus. J Clin Endocrinol Metab 83(2):693–696PubMedCrossRef
23.
Zurück zum Zitat Gagliardi PC, Bernasconi S, Repaske DR (1997) Autosomal dominant neurohypophyseal diabetes insipidus associated with a missense mutation encoding Gly23 –> Val in neurophysin II. J Clin Endocrinol Metab 82(11):3643–3646PubMedCrossRef Gagliardi PC, Bernasconi S, Repaske DR (1997) Autosomal dominant neurohypophyseal diabetes insipidus associated with a missense mutation encoding Gly23 –> Val in neurophysin II. J Clin Endocrinol Metab 82(11):3643–3646PubMedCrossRef
24.
Zurück zum Zitat Chitturi S, Harris M, Thomsett MJ, Bowling F, McGown I, Cowley D et al (2008) Utility of AVP gene testing in familial neurohypophyseal diabetes insipidus. Clin Endocrinol (Oxf) 69(6):926–930CrossRef Chitturi S, Harris M, Thomsett MJ, Bowling F, McGown I, Cowley D et al (2008) Utility of AVP gene testing in familial neurohypophyseal diabetes insipidus. Clin Endocrinol (Oxf) 69(6):926–930CrossRef
25.
Zurück zum Zitat Leger J, Velasquez A, Garel C, Hassan M, Czernichow P (1999) Thickened pituitary stalk on magnetic resonance imaging in children with central diabetes insipidus. J Clin Endocrinol Metab 84(6):1954–1960PubMedCrossRef Leger J, Velasquez A, Garel C, Hassan M, Czernichow P (1999) Thickened pituitary stalk on magnetic resonance imaging in children with central diabetes insipidus. J Clin Endocrinol Metab 84(6):1954–1960PubMedCrossRef
26.
Zurück zum Zitat Ramelli GP, von der Weid N, Stanga Z, Mullis PE, Buergi U (1998) Suprasellar germinomas in childhood and adolescence: diagnostic pitfalls. J Pediatr Endocrinol Metab 11(6):693–697PubMedCrossRef Ramelli GP, von der Weid N, Stanga Z, Mullis PE, Buergi U (1998) Suprasellar germinomas in childhood and adolescence: diagnostic pitfalls. J Pediatr Endocrinol Metab 11(6):693–697PubMedCrossRef
Metadaten
Titel
Polyuria and polydipsia in a young child: diagnostic considerations and identification of novel mutation causing familial neurohypophyseal diabetes insipidus
verfasst von
Matthew D. Stephen
Raymond G. Fenwick
Patrick G. Brosnan
Publikationsdatum
01.12.2012
Verlag
Springer US
Erschienen in
Pituitary / Ausgabe Sonderheft 1/2012
Print ISSN: 1386-341X
Elektronische ISSN: 1573-7403
DOI
https://doi.org/10.1007/s11102-010-0230-y

Weitere Artikel der Sonderheft 1/2012

Pituitary 1/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.